CME and 3 Stocks Spilling to 52-Week Lows

CME Group (NASDAQ:CME) bottoms at 52-weeks as the Commodity Futures Trading Commission, or CFTC reportedly expands its MF Global investigation to include activity at the futures exchange in the days leading up to the collapse. CME did not properly ensure customer money was protected as MF careened towards bankruptcy, or so is the thought, and thus the investigation by the CFTC. CME shares closed at $228.24, down $5.76 or 2.46% on the day. They have traded in a 52-week range of $229.53 to $318.37.

Brean Murray has cut Abercrombie & Fitch (NYSE:ANF) to Hold, changing the price target to $70. Weak holiday sales and high discounting from its peers, as well as international economic uncertainty impacting on its sales was cited by Abercrombie. ANF shares closed at $45.63, up $0.72 or 1.6% on the day. They have traded in a 52-week range of $44.22 to $78.25.

Following Friday’s Q4 earnings warning, IPC The Hospitalist(NASDAQ:IPCM) extends its losses, down from a 21.6% premarket. Adding to this, Jefferies downgrades IPC to Hold from Buy, and a reduced price target of $40. Finally, Dougherty & Company did the same, downgrading IPC from Buy to Neutral, and the target price from $56 to $41. IPCM shares closed at $30.61, down $15.04 or 32.95% on the day. They have traded in a 52-week range of $35.08 to $52.25.

Shares of Theravance (NASDAQ:THRX) crater after the firm’s Phase III results for Relovair includes the disclosure of pneumonia-related deaths in patients. Theravence shares closed at $16.39, down $3.81 or 18.86% on the day. They have traded in a 52-week range of $16.44 to $28.95.

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com